세계의 바이오프로세스 자동화 시장 보고서(2025년)
Bioprocess Automation Global Market Report 2025
상품코드 : 1818854
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,471,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,354,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,236,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오프로세스 자동화 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 연평균 복합 성장률(CAGR) 12.6%로 102억 2,000만 달러로 성장할 전망입니다. 예측기간의 성장은 생산성 향상, 규제 준수, 공정 최적화, 예측 유지보수, 실시간 분석으로 인한 것으로 예측됩니다. 예측기간의 주요 동향으로는 AI와 머신러닝의 통합, 모듈형 바이오프로세스, 유전자 치료의 공정 제어 전략, 데이터 분석 및 시각화 등이 있습니다.

향후 5년간의 예측 성장률 12.6%는 과거 예측으로부터 0.2% 소폭 감소한 수치입니다. 이러한 성장 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 이는 스위스나 한국에서 수입되는 바이오리액터 제어 유닛과 유체 센서에 대한 관세 인상을 통해 미국에 직접 영향을 미칠 가능성이 높아 의약품 및 생명공학 제조의 확장성을 저해할 가능성이 있습니다. 또한 상호관세 및 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 늘어날 것으로 예상됩니다.

맞춤 의료의 증가는 향후 바이오프로세스 자동화 시장의 성장을 가속할 것으로 예측됩니다. 맞춤 의료는 건강 관리의 결정, 실천, 개입, 치료를 각 환자의 특성에 맞게 조정하는 의료 접근법을 말합니다. 바이오프로세스 자동화는 환자에 특화된 의약품을 제조할 때 정확성과 확장성을 가능하게 함으로써 맞춤 의료를 지원합니다. 예를 들어, 미국의 전문가 회원 조직 맞춤형의료연합(Personalized Medicine Coalition)에 따르면, 2022년에 새로 승인된 치료법 전체의 약 34%를 차지하는 12개의 개별화 신약이 승인되었으며 이전보다 크게 증가하였습니다. 따라서 맞춤 의료의 증가는 바이오프로세스 자동화 시장의 성장을 이끌고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Bioprocess automation is using automated systems to monitor and control the bioprocessing workflow, which involves living cells, organisms, or components to produce biological products such as biopharmaceuticals. Biopharmaceutical businesses use bioprocess automation for better process control and optimization, higher product quality, decreased variability, increased throughput and efficiency, cost savings, and scalability.

The main components of bioprocess automation are sensors, actuators, and controllers. Sensors are devices that detect and respond to inputs from the physical environment, converting them into electronic signals, which are used to monitor various parameters such as temperature, pH, dissolved oxygen, and pressure. The scale of operation includes preclinical operations, clinical operations, and commercial operations with batch, fed-batch, and perfusion modes of compatibility with bioprocessing systems include single-use systems, stainless steel, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and rising trade tensions in spring 2025 are having a substantial impact on the machinery sector, driving up the costs of essential components such as steel, hydraulic systems, and precision bearings many of which are sourced from regions affected by the tariffs. Manufacturers of construction, agricultural, and industrial machinery are now facing tighter profit margins, as existing long-term contracts limit their ability to raise prices immediately. This climate of uncertainty has also led to postponed investments in automation and smart machinery, slowing potential productivity improvements. In response, companies are focusing on developing local suppliers, redesigning products to incorporate alternative materials, and adopting predictive maintenance strategies to extend equipment life and reduce the need for costly replacements.

The main components of bioprocess automation are sensors, actuators, and controllers. Sensors are devices that detect and respond to inputs from the physical environment, converting them into electronic signals, which are used to monitor various parameters such as temperature, pH, dissolved oxygen, and pressure. The scale of operation includes preclinical operations, clinical operations, and commercial operations with batch, fed-batch, and perfusion modes of compatibility with bioprocessing systems include single-use systems, stainless steel, and others.

The bioprocess automation market size has grown rapidly in recent years. It will grow from $5.67 billion in 2024 to $6.35 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to increased efficiency, cost reduction, risk mitigation, rising demand for remote monitoring and control, and reduced labor dependency.

The bioprocess automation market size is expected to see rapid growth in the next few years. It will grow to $10.22 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to enhanced productivity, regulatory compliance, process optimization, predictive maintenance predictive maintenance, and real-time analytics. Major trends in the forecast period include integration of ai and machine learning, modular bioprocessing, process control strategies for gene therapy, process control strategies for gene therapy, and data analytics and visualization.

The forecast of 12.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased duties on bioreactor control units and fluid sensors imported from Switzerland and South Korea, potentially hindering the scalability of pharmaceutical and biotech manufacturing. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing number of personalized medicines is expected to fuel the growth of the bioprocess automation market going forward. Personalized medicine refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to the individual characteristics of each patient. Bioprocess automation helps personalized medicine by enabling precision and scalability in producing patient-specific drugs. For instance, according to Personalized Medicine Coalition, a US-based professional membership organization, in 2022, approving 12 new personalized medicines represented approximately 34% of all newly approved therapies, indicating a substantial increase from previous years. Therefore, the increasing number of personalized medicines is driving the growth of the bioprocess automation market.

Major companies operating in the bioprocess automation market are developing innovative solutions, such as bioreactors to simplify bioprocessing operations. A bioreactor is an engineered system or device that provides an optimal and controlled environment for biological and chemical reactions. For instance, in April 2023, Cytiva, a US-based technology company that provides technologies and services that help advance and accelerate the development and manufacture of therapeutics, launched X-platform bioreactors to simplify single-use upstream bioprocessing operations. It is easy to operate, flexible, and more efficient in the process. It was first offered in 50 and 200 L capacities. They can increase process efficiency through ergonomic improvements, production capability, and simplified supply chain operations. The X-platform bioreactors can be used to manufacture cell and gene therapies as well as viral vectors, in addition to monoclonal antibodies (mAbs).

In April 2022, MilliporeSigma, a US-based life science division of Merck KGaA, acquired Lonza's Modular Automated Sampling Technology (MAST) platform for an undisclosed amount. This acquisition is designed to enhance MilliporeSigma's position in the bioprocessing market by expanding its portfolio of tools for biopharmaceutical manufacturing. By integrating the MAST platform, MilliporeSigma aims to offer more advanced and automated solutions for the pharmaceutical, biotechnology, and nutrition sectors. Lonza, a Switzerland-based company, is a key player in the manufacturing industry serving these sectors. This move strengthens MilliporeSigma's capabilities in the rapidly growing bioprocessing industry.

Major companies operating in the bioprocess automation market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Corporation, Danaher Corporation, Amgen Inc., Merck KGaA, Parker-Hannifin Corporation, CSL Behring LLC, Rockwell Automation Inc., Agilent Technologies Inc., Lonza Group AG, Waters Corporation, Getinge AB, Eppendorf AG, Repligen Corporation, BIONET Research S.A., Flotek Industries Inc., Pierre Guerin SAS, Bioengineering AG, Genedata AG, ILS Automation, INFORS AG, Synthace Limited, Automated Control Concepts Inc., BlueSens gas sensor GmbH, DISTek Integration Inc., Securecell AG, Flownamics Analytical Instruments Inc., Inscripta Inc., PendoTECH Inc., Sartorius Stedim Biotech S.A.

North America was the largest region in the bioprocess automation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess automation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioprocess automation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioprocess automation market includes revenues earned by entities by providing services such as process automation, instrumentation and control systems, training and support services, and maintenance and upgrades. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioprocess automation market also includes sales of bioreactors, fermenters, laboratory information management systems (LIMS), and integrated bioprocess platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioprocess Automation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioprocess automation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bioprocess automation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioprocess automation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Bioprocess Automation Market Characteristics

3. Bioprocess Automation Market Trends And Strategies

4. Bioprocess Automation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bioprocess Automation Growth Analysis And Strategic Analysis Framework

6. Bioprocess Automation Market Segmentation

7. Bioprocess Automation Market Regional And Country Analysis

8. Asia-Pacific Bioprocess Automation Market

9. China Bioprocess Automation Market

10. India Bioprocess Automation Market

11. Japan Bioprocess Automation Market

12. Australia Bioprocess Automation Market

13. Indonesia Bioprocess Automation Market

14. South Korea Bioprocess Automation Market

15. Western Europe Bioprocess Automation Market

16. UK Bioprocess Automation Market

17. Germany Bioprocess Automation Market

18. France Bioprocess Automation Market

19. Italy Bioprocess Automation Market

20. Spain Bioprocess Automation Market

21. Eastern Europe Bioprocess Automation Market

22. Russia Bioprocess Automation Market

23. North America Bioprocess Automation Market

24. USA Bioprocess Automation Market

25. Canada Bioprocess Automation Market

26. South America Bioprocess Automation Market

27. Brazil Bioprocess Automation Market

28. Middle East Bioprocess Automation Market

29. Africa Bioprocess Automation Market

30. Bioprocess Automation Market Competitive Landscape And Company Profiles

31. Bioprocess Automation Market Other Major And Innovative Companies

32. Global Bioprocess Automation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioprocess Automation Market

34. Recent Developments In The Bioprocess Automation Market

35. Bioprocess Automation Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기